[Results of a clinical comparative double blind test between the 2 topical corticoides, 17-desoxymethasone and betamethasone, in the treatment of psoriasis].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001623:Betamethasone / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D001623:Betamethasone
Resultados de un ensayo clínico comparativo doble ciego entre dos corticoides tópicos 17-desoximetasona y betametasona aplicados al tratamiento del psoriásis.